Drug demonstrates poor efficacy in advanced bladder cancer
Could the COVID vaccines affect your period? We don’t know yet—but there’s no cause for concern
30 April 2021Mindfulness programs can boost children’s mental health
30 April 2021Drug demonstrates poor efficacy in advanced bladder cancer
An FDA-approved monoclonal antibody drug used to treat advanced bladder cancer demonstrated poor efficacy in a recent clinical trial published in The Lancet Oncology.
